Edit Porpaczy

1.3k total citations
27 papers, 614 citations indexed

About

Edit Porpaczy is a scholar working on Pathology and Forensic Medicine, Genetics and Molecular Biology. According to data from OpenAlex, Edit Porpaczy has authored 27 papers receiving a total of 614 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pathology and Forensic Medicine, 9 papers in Genetics and 6 papers in Molecular Biology. Recurrent topics in Edit Porpaczy's work include Lymphoma Diagnosis and Treatment (14 papers), Chronic Lymphocytic Leukemia Research (9 papers) and CAR-T cell therapy research (4 papers). Edit Porpaczy is often cited by papers focused on Lymphoma Diagnosis and Treatment (14 papers), Chronic Lymphocytic Leukemia Research (9 papers) and CAR-T cell therapy research (4 papers). Edit Porpaczy collaborates with scholars based in Austria, United Kingdom and United States. Edit Porpaczy's co-authors include Ulrich Jaeger, Alexander Gaiger, Markus Raderer, Cathrin Skrabs, Ulrich Jäger, Medhat Shehata, Ingrid Simonitsch‐Klupp, Birgit Kainz, Leonhard Müllauer and Andreas Gleiß and has published in prestigious journals such as Blood, PLoS ONE and Clinical Cancer Research.

In The Last Decade

Edit Porpaczy

27 papers receiving 611 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Edit Porpaczy Austria	15	218	192	176	160	105	27	614
Shizuyo Tsujimura Japan	16	234 1.1×	89 0.5×	224 1.3×	101 0.6×	136 1.3×	33	969
Marwan Yared United States	12	176 0.8×	192 1.0×	39 0.2×	103 0.6×	73 0.7×	20	523
L. Schwartzberg United States	14	376 1.7×	95 0.5×	48 0.3×	117 0.7×	70 0.7×	61	640
Ralph P. Ermoian United States	15	126 0.6×	74 0.4×	140 0.8×	220 1.4×	179 1.7×	55	680
Maciej Kaźmierczak Poland	13	90 0.4×	102 0.5×	61 0.3×	161 1.0×	93 0.9×	41	475
Paraskevi Roussou Greece	13	138 0.6×	120 0.6×	40 0.2×	100 0.6×	152 1.4×	21	528
Jonathan Lambert United Kingdom	12	122 0.6×	143 0.7×	57 0.3×	79 0.5×	86 0.8×	28	476
Deniz Şahin Türkiye	12	269 1.2×	378 2.0×	133 0.8×	48 0.3×	164 1.6×	52	594
Antònia Sampol Spain	14	189 0.9×	147 0.8×	44 0.3×	117 0.7×	153 1.5×	60	731
Ara Dikranian United States	8	134 0.6×	96 0.5×	125 0.7×	77 0.5×	192 1.8×	18	917

Countries citing papers authored by Edit Porpaczy

Since Specialization

Citations

This map shows the geographic impact of Edit Porpaczy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edit Porpaczy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edit Porpaczy more than expected).

Fields of papers citing papers by Edit Porpaczy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edit Porpaczy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edit Porpaczy. The network helps show where Edit Porpaczy may publish in the future.

Co-authorship network of co-authors of Edit Porpaczy

This figure shows the co-authorship network connecting the top 25 collaborators of Edit Porpaczy. A scholar is included among the top collaborators of Edit Porpaczy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edit Porpaczy. Edit Porpaczy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Koblischke, Maximilian, Lisa Schneider, Edit Porpaczy, et al.. (2022). Immunogenicity of COVID-19 Vaccinations in Hematological Patients: 6-Month Follow-Up and Evaluation of a 3rd Vaccination. Cancers. 14(8). 1962–1962. 7 indexed citations

Berger, J.M., Oliver Königsbrügge, Hanna A. Knaus, et al.. (2022). SARS-CoV-2-related mortality and treatment delays for cancer patients in Austria. Wiener klinische Wochenschrift. 134(9-10). 371–376. 1 indexed citations

Porpaczy, Edit, Philipp Wohlfarth, Oliver Königsbrügge, et al.. (2021). Influence of TP53 Mutation on Survival of Diffuse Large B-Cell Lymphoma in the CAR T-Cell Era. Cancers. 13(22). 5592–5592. 17 indexed citations

Porpaczy, Edit, et al.. (2018). Increased lymphocyte cell size with blastoid morphology associated with splenic rupture following cessation of ibrutinib. British Journal of Haematology. 181(4). 431–431. 1 indexed citations

Mayerhoefer, Marius E., Markus Raderer, Ulrich Jaeger, et al.. (2018). Ultra-early response assessment in lymphoma treatment: [18F]FDG PET/MR captures changes in glucose metabolism and cell density within the first 72 hours of treatment. European Journal of Nuclear Medicine and Molecular Imaging. 45(6). 931–940. 18 indexed citations

Rabitsch, Werner, Philipp Wohlfarth, Edit Porpaczy, et al.. (2017). Gender-Specific Aspects in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation: A Single-Center Experience. Oncology. 93(5). 295–301. 6 indexed citations

Porpaczy, Edit, Trang Le, Michaela Gruber, et al.. (2016). Cannabinoid Receptors Are Overexpressed in CLL but of Limited Potential for Therapeutic Exploitation. PLoS ONE. 11(6). e0156693–e0156693. 14 indexed citations

Porpaczy, Edit, Marius E. Mayerhoefer, Ulrike Salzer‐Muhar, & Ulrich Jaeger. (2016). Lymphoma in Danon disease with chronic rhabdomyolysis treated with EPOCH-R. Medicine. 95(29). e4237–e4237. 1 indexed citations

Wohlfarth, Philipp, Thomas Staudinger, Alexander Hermann, et al.. (2016). Incidence of intensive care unit admission, outcome and post intensive care survival in patients with diffuse large B-cell lymphoma. Leukemia & lymphoma. 57(8). 1831–1838. 19 indexed citations

10.

Masel, Eva Katharina, Tamara Rumpold, Matthias Unseld, et al.. (2016). What Makes a Good Palliative Care Physician? A Qualitative Study about the Patient’s Expectations and Needs when Being Admitted to a Palliative Care Unit. PLoS ONE. 11(7). e0158830–e0158830. 28 indexed citations

11.

Mayerhoefer, Marius E., Georgios Karanikas, Kurt Kletter, et al.. (2015). Evaluation of Diffusion-Weighted Magnetic Resonance Imaging for Follow-up and Treatment Response Assessment of Lymphoma: Results of an 18F-FDG-PET/CT–Controlled Prospective Study in 64 Patients. Clinical Cancer Research. 21(11). 2506–2513. 66 indexed citations

12.

Schiefer, Ana‐Iris, Christoph Kornauth, Ingrid Simonitsch‐Klupp, et al.. (2015). Impact of Single or Combined Genomic Alterations of TP53, MYC, and BCL2 on Survival of Patients With Diffuse Large B-Cell Lymphomas. Medicine. 94(52). e2388–e2388. 19 indexed citations

13.

Schneeweiss‐Gleixner, Mathias, Edit Porpaczy, Martin Koch, et al.. (2015). Transformed mycosis fungoides: bridging to allogeneic stem cell transplantation with brentuximab vedotin. Leukemia & lymphoma. 57(1). 206–208. 6 indexed citations

14.

Mayerhoefer, Marius E., Georgios Karanikas, Kurt Kletter, et al.. (2014). Evaluation of Diffusion-Weighted MRI for Pretherapeutic Assessment and Staging of Lymphoma: Results of a Prospective Study in 140 Patients. Clinical Cancer Research. 20(11). 2984–2993. 81 indexed citations

15.

Porpaczy, Edit, Stefanie Tauber, Martin Bilban, et al.. (2013). Lipoprotein lipase in chronic lymphocytic leukaemia – Strong biomarker with lack of functional significance. Leukemia Research. 37(6). 631–636. 16 indexed citations

16.

Atamaniuk, Johanna, Andreas Gleiß, Edit Porpaczy, et al.. (2012). Overexpression of G protein‐coupled receptor 5D in the bone marrow is associated with poor prognosis in patients with multiple myeloma. European Journal of Clinical Investigation. 42(9). 953–960. 101 indexed citations

17.

Weiss, Patricia M., Edit Porpaczy, Trang Le, et al.. (2012). Cannabinoid Receptor 1 in Chronic Lymphocytic Leukemia: Strong Prognostic Marker with Limited Therapeutic Use. Blood. 120(21). 4565–4565. 1 indexed citations

18.

Vanura, Katrina, Andreas Gleiß, Trang Le, et al.. (2011). Prevalence and clinical impact of autoimmune diseases and chronic infections in malignant lymphomas at diagnosis. Annals of Hematology. 90(8). 947–954. 4 indexed citations

19.

Gruber, Michaela, Edit Porpaczy, Cathrin Skrabs, et al.. (2011). Prolonged progression-free survival in patients with chronic lymphocytic leukemia receiving granulocyte colony-stimulating factor during treatment with fludarabine, cyclophosphamide, and rituximab. Annals of Hematology. 90(10). 1131–1136. 10 indexed citations

20.

Bilban, Martin, Daniel Heintel, Theresa Scharl, et al.. (2006). Deregulated expression of fat and muscle genes in B-cell chronic lymphocytic leukemia with high lipoprotein lipase expression. Leukemia. 20(6). 1080–1088. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact